Comparative Clinical Efficacy of Guduchyadi Syrup and Guduchyadi Ghanvati in Management of Amlapitta
Introduction: Amalpitta is most common problem nowadays. Guduchyadi yoga kwatha was indicated in classics in the management of Amlapitta. Kwatha is very effective but it is unpleasant to some patients. So the kwatha was converted into preferable dosage form as requirement of present era. Material and Method: A Clinical trial was carried out on 60 Patients of Amlapitta aged 20 to 60 years with complaints of Aruchi, Avipaka, Tiktodgar, Amlodgar, Urodaha, Kanthadaha etc., who were registered from OPD of Government Ayurved Hospital, Vadodara. They were equally divided into two groups i.e. Group A- Guduchyadi Syrup given in 20ml BD dose and Group B- Guduchyadi Ghanavati given at 500mg2 BD ). Each group was treated for 28 days administered empty stomach. The clinical assessment was carried out on the 28th day and 2 weeks after the 28 days of treatment (after follow up period) for the objective & subjective parameters and it was seen that both the dosage form Guduchyadi Syrup and Guduchyadi Ghanavati were very effective and cured or markedly relieved the symptoms of Amlapitta. Results: The study shows the effect of Guduchyadi Syrup and Guduchyadi Ghanavati, which led to cure in 16 patients (53.33%) and 22(73.33%) patients respectively, and markedly improvement in 12(40%) and 8(26.67%) patients affected with Amlapitta disease respectively. Conclusion: Both trial dosage forms of Guduchyadi Yoga, (Group A- Syrup & Group B- Ghanavati ) relieved the symptoms of Amlapitta and both the formulation have comparatively similar efficacy in the management of Amlapitta.
Copyright (c) 2020 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.